Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vera Krane

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 4, 2003
Non-high-density lipoprotein cholesterol: a target of lipid-lowering in dialysis patientsChristoph Wanner, Vera Krane
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 19, 2002
The metabolic burden of diabetes and dyslipidaemia in chronic kidney diseaseVera Krane, Christoph Wanner
Blood Purification|September 11, 2002
Uremia-specific alterations in lipid metabolismChristoph Wanner, Vera Krane
Nature Clinical Practice. Nephrology|August 26, 2006
At which stage of chronic kidney disease should dyslipidemia be treated?Vera Krane, Christoph Wanner
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 9, 2005
Statins and aspirin in chronic kidney disease: what does the UK-HARP-I trial tell us?Vera Krane, Christoph Wanner
Kidney & Blood Pressure Research|June 22, 2011
Recent advances in the treatment of atherogenic dyslipidemia in type 2 diabetes mellitusChristoph Wanner, Vera Krane
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 19, 2016
Should we aim for oral health to improve outcomes in chronic kidney disease?Vera Krane, Christoph Wanner
Nephrologie & Therapeutique|August 10, 2006
Lessons learnt from the 4D trialChristoph Wanner, Vera Krane
Journal of the American Society of Nephrology : JASN|June 18, 2011
Sunrise of statins after AURORA and 4D?Christoph Wanner, Vera Krane
Nature Reviews. Nephrology|June 2, 2011
Statins, inflammation and kidney diseaseVera Krane, Christoph Wanner
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 4, 2003
Non-high-density lipoprotein cholesterol: a target of lipid-lowering in dialysis patientsChristoph Wanner, Vera Krane
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 19, 2002
The metabolic burden of diabetes and dyslipidaemia in chronic kidney diseaseVera Krane, Christoph Wanner
Blood Purification|September 11, 2002
Uremia-specific alterations in lipid metabolismChristoph Wanner, Vera Krane
Nature Clinical Practice. Nephrology|August 26, 2006
At which stage of chronic kidney disease should dyslipidemia be treated?Vera Krane, Christoph Wanner
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 9, 2005
Statins and aspirin in chronic kidney disease: what does the UK-HARP-I trial tell us?Vera Krane, Christoph Wanner
Kidney & Blood Pressure Research|June 22, 2011
Recent advances in the treatment of atherogenic dyslipidemia in type 2 diabetes mellitusChristoph Wanner, Vera Krane
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 19, 2016
Should we aim for oral health to improve outcomes in chronic kidney disease?Vera Krane, Christoph Wanner
Nephrologie & Therapeutique|August 10, 2006
Lessons learnt from the 4D trialChristoph Wanner, Vera Krane
Journal of the American Society of Nephrology : JASN|June 18, 2011
Sunrise of statins after AURORA and 4D?Christoph Wanner, Vera Krane
Nature Reviews. Nephrology|June 2, 2011
Statins, inflammation and kidney diseaseVera Krane, Christoph Wanner
Pageof 10